Ensure healthy lives and promote well-being for all at all ages
Metabolic Steatotic Liver Disease: Current Knowledge, Therapeutic Treatments, and Future Directions, 2024, Pages 261-275
This content aligns with Goal 3: Good Health as this chapter will review the aspects of combined viral hepatitis and FLD, including prevalence, risk factors, natural history, pathogenesis, and management to help inform the reader of the complexity of these liver diseases.
Remington and Klein's Infectious Diseases of the Fetus and Newborn Infant (Ninth Edition), 2025, Pages 728-744.e4
This content aligns with Goal 3: Good Health. Public health programs at the governmental level are in need for prevention of the maternal-fetal transmission of these viruses and access to available antiviral therapies.
Digital Healthcare in Asia and Gulf Region for Healthy Aging and More Inclusive Societies: Shaping Digital Future, 2024, pp 331-352
This content aligns with Goal 3: Good Health provides understanding the mechanisms involved in AIH pathogenesis controlling hepatitic inflammation.
Bioreactor Design Concepts for Viral Vaccine Production: Progress in Biochemistry and Biotechnology, 2024, Pages 297-310
This content aligns with Goal 3: Good Health The chapter provides information on a cost-effective and easy way to produce the vaccine grade HCV.
